RE:RE:RE:33808620 sh. @ .29 (plus a 1/2 warrant @.40 till Sept.2015) Blartar, I don't know anything more than you. I am simply speculating on a pattern that seems to repeat itself in Canadian biotech. Enough concrete news that should generate a run in the SP, but has little to no apparent effect. However, what you don't see is that the development(s) will generate an insider frenzy for a dirt placement at mine and your expense.
Is there any other reason the SP trades where it does? Summer vacation, reputation blah, blah, blah.
isnt that a little too simple to justify a 40 mil market cap on a P3 cancer submission... Not a maybe, a full FDA submissIn for approval.
I suspect 50 mil at 32 cents just about covers things until that FDA decision comes down. Oh, and there will be no rights offering to protect your retail equity position. I'd bet its all spoken for already.
A lot of wheels took a beating on the$1.45 placement. What better way to ingratiate your company with them again than to hand them an auto 5 bagger at 30 cents.
that is really just a hunch Blartar.